ahlam1399
08-04-2015, 09:33 PM
Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta
LONDON (Reuters) - Drugmaker Shire said on Tuesday it was seeking to buy Baxalta , a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654200/s/48b3916e/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=sM8YIsmdV9o:ixd3SKjw24o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=sM8YIsmdV9o:ixd3SKjw24o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=sM8YIsmdV9o:ixd3SKjw24o:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=sM8YIsmdV9o:ixd3SKjw24o:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=sM8YIsmdV9o:ixd3SKjw24o:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/sM8YIsmdV9o
LONDON (Reuters) - Drugmaker Shire said on Tuesday it was seeking to buy Baxalta , a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654200/s/48b3916e/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=sM8YIsmdV9o:ixd3SKjw24o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=sM8YIsmdV9o:ixd3SKjw24o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=sM8YIsmdV9o:ixd3SKjw24o:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=sM8YIsmdV9o:ixd3SKjw24o:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=sM8YIsmdV9o:ixd3SKjw24o:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/sM8YIsmdV9o